Neuberger Berman Canada’s AbbVie ABBV Stock Holding History

Neuberger Berman Canada’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$13.5M	Buy	151,868 +8,643	+6%	+$658K	2.49%	4
2017 Q2	$10.4M	Sell	143,225 -52,440	-27%	-$3.53M	1.94%	11
2017 Q1	$12.8M	Buy	195,665 +16,283	+9%	+$1.02M	2.5%	1
2016 Q4	$11.2M	Buy	179,382 +17,489	+11%	+$1.07M	2.84%	2
2016 Q3	$10.2M	Buy	161,893 +31,108	+24%	+$2.01M	3.1%	2
2016 Q2	$8.1M	Buy	130,785 +18,058	+16%	+$1.1M	2.6%	9
2016 Q1	$6.44M	Buy	+112,727	New	+$6.28M	2.37%	10
2015 Q1	–	Sell	-4,593	Closed	-$301K	–	177
2014 Q4	$301K	Buy	+4,593	New	+$290K	0.05%	269
2013 Q4	–	Sell	-15,900	Closed	-$711K	–	235
2013 Q3	$711K	Buy	+15,900	New	+$705K	0.21%	141

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Neuberger Berman Canada's ABBV Position: Q3 2017 in Review

Neuberger Berman Canada increased its AbbVie (ABBV) stake by 6% in Q3 2017, buying an estimated $658K and bringing the position to 151,868 shares worth $13.5M. The position accounts for 2.49% of the portfolio, ranked #4.

Neuberger Berman Canada first reported a position in ABBV in Q3 2013 and has held it in 9 quarters since. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

Neuberger Berman Canada held 151,868 shares of AbbVie worth $13.5M as of Q3 2017.
Neuberger Berman Canada bought 8,643 AbbVie shares in Q3 2017, an estimated $658K.
AbbVie made up 2.49% of Neuberger Berman Canada's portfolio in Q3 2017, its #4 holding.
Neuberger Berman Canada first reported a position in AbbVie in Q3 2013 and has held it in 9 quarters since.
1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on Neuberger Berman Canada's 13F filing for Q3 2017, filed 3 Nov 2017.